openPR Logo
Press release

Heart Failure Software Market: Global Industry Analysis 2024

05-26-2017 01:07 AM CET | Health & Medicine

Press release from: Transparency Market Research

Heart Failure Software Market: Global Industry Analysis 2024

The global heart failure software market is growing significantly due to changing healthcare system. Rising demand for monitored care for individual health has in turn increased demand for heart failure software. Technological advancements and increased accessibility to personal healthcare systems are some factors projected to drive growth of the heart failure software market.

Get accurate market forecast and analysis on the Heart Failure Software Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16289

Rising need for continuous health assessment and dynamic advancements in technology have introduced various applications of clinical decision support system such as heart failure software system. Heart failure software enables management of cardiac patients safely and efficiently. It offers support to patients in cardiac activity monitoring and analyzing risk zone of patients with cardiac diseases. Documenting, assessment, activity monitoring, referrals, communicating between physicians for treatment, follow up, etc. are activities carried out through heart failure software. Thus, it is deployed by hospitals, cardiac clinics and other clinical facilities for continuous assessment and monitoring of patients. With patient numbers increasing due to the combined effects of improved survival after heart attack and an ageing population, the management of heart failure patients will continue to have a significant impact on healthcare resources. Thus, driving growth of the heart failure software market. Continuous monitoring of cardiac condition helps improve treatment compliance, improves control on symptoms, decrease patients clinical visits, improves patient outcome, enables detailed investigation for the cardiac symptoms, etc.

Rising health awareness, increasing demand for continuous health monitoring, and shifting consumer preference towards a healthy lifestyle has led the heart failure software market to upsurge substantially. Technological advancements have led to the emergence of various health monitoring devices such as remote patient monitoring, activity tracker and wearable medical devices that in turn are expected to drive growth of the heart failure software market. Moreover, rising need for continuous monitoring of health in lifestyle diseases such as cardiac arrest, hypertension, etc. has led to increase in demand for heart failure software.

Increasing demand for access to patient health records (PHR/ PHI) is the important factor leading to Heart Failure Software market growth. Awareness is the important factor for increasing the adoption rate for Heart Failure Software. Thus, government and various international organization across the globe are being involved in various initiatives undertaken to increase the awareness about the monitoring devices. Various government and non – government organization continuously operates in development of advanced healthcare solutions by offering funds, leveraging technology and skills. For an instance, according to study published by Wolters Kluwers in 2016, the use of clinical decision support system for heart failure patients has shown improved health outcomes in patients and decrease in readmissions.

In terms of type of model, heart failure software market is categorized into knowledge based and non – knowledge based. Knowledge based heart failure software was observed with relatively significant demand than the other. However, the challenges reported in the type of models is the interoperability of different systems or platforms existing in hospital and clinical setup. Moreover, increasing advancement in personal medical devices is anticipated to exert positive impact on overall heart failure software market.

In terms of delivery mode, heart failure software market is segmented into web-based, on-premises and cloud-based systems. Cloud based systems is the fastest growing segment in the market.

In terms of end users, hospital segment is expected to account for major share in heart failure software market, due to increasing adoption of electronic health records (EHR) and remote patient monitoring system. Rising awareness about personal health amongst the population is expected to drive growth of the consumer segment over the near future.

By geography, due to high adoption rate of technology and improved healthcare policies has made North America to occupy the significant market share in heart failure software market, followed by rest developed markets like Europe. US have been the largest market across the globe. The dominance of North America is due to factors like well-established healthcare and technology infrastructure, rising awareness level, and extensive internet coverage across the region, etc. However, Asia Pacific is anticipated to grow at significant rate, following to developed regions like North America and Europe. Increase in disposable income, rising population, increasing demand for wearable monitoring health devices, increasing government intervention for development of healthcare infrastructure are the major factors leading to drive the Asia Pacific Market. In addition, increasing penetration of virtual healthcare systems like tele-health, e-health and m-health applications has led the significant positive impact on developing regions like Asia Pacific. Thus Asian market is reported with significant new entrants in the heart failure software market compared to rest of the world. China and India are anticipated as favorable market for new entrants in heart failure software sector.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/heart-failure-software-market.html

Most of the players in heart failure software market are focused to develop technologically advance and cost efficient system on the virtue of offering solution to customers like comfortable, compact, easy to use solution, etc. Due to rising competition in the market, the companies adopt various policies including strategic alliances, forward and backward integration, new product development, mergers and acquisitions, etc. in order to sustain the business in the market. The Major players reported in the market include Cerner Corporation, 4S Information Systems Ltd., Axis Clinical Software, Inc., CitiusTech Inc., etc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Failure Software Market: Global Industry Analysis 2024 here

News-ID: 552319 • Views:

More Releases from Transparency Market Research

Hypodermic Needles Market to Reach US$ 4 Billion by 2031: TMR Study
Hypodermic Needles Market to Reach US$ 4 Billion by 2031: TMR Study
The global 𝐡𝐲𝐩𝐨𝐝𝐞𝐫𝐦𝐢𝐜 𝐧𝐞𝐞𝐝𝐥𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 was worth US$ 2.1 Bn and is projected to reach a value of US$ 4 Bn by the end of 2031 and is anticipated to grow at a CAGR of 6% during the forecast period. A hypodermic needle, derived from "hypo" meaning under and "dermic" referring to the skin, is a hollow needle typically paired with a syringe for administering substances into the body or extracting fluids
Smart Healthcare Products Market to Gain Value of US$ 80.3 Billion by 2027, States TMR Study
Smart Healthcare Products Market to Gain Value of US$ 80.3 Billion by 2027, Stat …
Transparency Market Research's most recent report on the global 𝐬𝐦𝐚𝐫𝐭 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, covering the historical period of 2017-2018 and the forecast period from 2019-2027, highlights the driving forces behind its growth. Factors such as the rapid digitalization of the healthcare industry, an increase in the number of small and medium-sized enterprises (SMEs) and large enterprises involved in smart healthcare products, and governmental initiatives aimed at promoting smart healthcare are
Patient Engagement Solutions Market to Reach US$ 56.33 Billion during the Forecast Period, 2021-2028| TMR Study
Patient Engagement Solutions Market to Reach US$ 56.33 Billion during the Foreca …
Transparency Market Research's most recent report on the global 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐞𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, spanning from 2017 to 2028 for historical data and forecasting from 2021 to 2028, indicates that the surge in the quality of healthcare solutions and services, coupled with the growing adoption of electronic health records, is expected to propel the global market forward throughout the forecast period. In 2020, the worldwide industry achieved a valuation of US$ 17.56
Renewable Naphtha Market is expected to surpass the value US$ 21.4 Bn by 2031
Renewable Naphtha Market is expected to surpass the value US$ 21.4 Bn by 2031
Renewable naphtha, derived from renewable sources such as biomass, bio-waste, or even carbon recycling, represents a crucial component in the transition towards cleaner energy alternatives. Its versatile applications across various industries, including petrochemicals, transportation, and power generation, underscore its significance in decarbonizing economies globally. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78850&utm_source=OPENPR%2FJayashrib&utm_campaign=OPENPR Market Size and Growth: The renewable naphtha market is poised for exponential growth, with analysts forecasting a robust CAGR throughout the forecast period.

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an